Translational durability and long-term safety remain unresolved
We offer a holistic plan to support your well-being with prescription medication, lifestyle content, and a nutrition plan tailored to your unique needs
Clinical trials showed modest fat loss of roughly 2-3 kg over 12 weeks, and the compound was never approved as a pharmaceutical because efficacy did not meet the threshold for drug registration (Heffernan et al., 2001)
Reconstitution note: Tesamorelin is strongly cationic and prone to injection-site welts, so reconstitute with 0.9% NaCl bacteriostatic water rather than plain BAC water the sodium and chloride ions screen the peptides charge and shrink the welt
Because AOD9604 is not FDAapproved and cannot be compounded under current guidance, it is offered only under a strict informed consent framework with full transparency about its investigational status, potential risks, and mixed efficacy data
Every product batch number links directly to independent analytical testing documents generated by qualified testing facilities